4.5 Bone Marrow Examination, Differential & M:E Ratio Assessment

Bone Marrow Examination, Differential & M:E Ratio Assessment

Bone marrow evaluation is an indispensable diagnostic procedure in hematology that provides direct assessment of hematopoietic cellularity, lineage maturation, storage iron reserves, and structural architecture. Comprehensive evaluation integrates clinical findings with peripheral blood counts, aspirate cytomorphology, core biopsy histology, cytochemical stains, flow cytometry, cytogenetics, and molecular testing.

                      BONE MARROW EVALUATION
                                 │
         ┌───────────────────────┴───────────────────────┐
         ▼                                               ▼
SPECIMEN COMPONENTS & KINETICS                  QUANTITATIVE PARAMETERS
  • Posterior Superior Iliac Spine (PSIS)         • Cellularity Formula: (100 - Age) ± 10%
  • Aspirate: Cytomorphology, 500-cell diff       • 500-Cell Aspirate Differential Count
  • Core Biopsy: Architecture, cellularity,       • Myeloid-to-Erythroid (M:E) Ratio:
    fibrosis (WHO MF 0–3)                             - Normal: 1.5:1 to 3.0:1 (up to 4:1)
  • Touch Imprints: Critical in "Dry Tap"             - Strict Inclusion/Exclusion Rules
    (Myelofibrosis, Hairy Cell Leukemia)          • Prussian Blue Stain: Hemosiderin & Sideroblasts

---

1. Specimen Collection, Anatomical Sites & Anticoagulant Protocol

Anatomical Biopsy Sites

• Posterior Superior Iliac Spine (PSIS): The standard, safest, and most universally utilized anatomical site for bone marrow aspiration and trephine core biopsy in adults, children, and infants. The anterior superior iliac spine (ASIS) is an alternative in severely obese or supine immobilized patients.
• Sternum: Aspiration-only site reserved strictly for adults ($>18\text{ years}$) when iliac crests are inaccessible.

  Critical Safety Warning: Trephine core biopsy of the sternum is ABSOLUTELY CONTRAINDICATED due to the catastrophic risk of penetrating the thin posterior sternal plate into the ascending aorta, right ventricle, pericardium, or anterior mediastinum.

• Tibia (Anteromedial Surface): Reserved exclusively for infants younger than $12\text{ to }18\text{ months}$ of age; ceases to contain active red marrow after infancy.

Specimen Fractions and Anticoagulant Requirements

                     ASPIRATE ANTICOAGULANT ASSIGNMENT

  ┌───────────────────────────────────────────────────────────┐
  │ EDTA (Lavender Top):                                      │
  │ • Morphologic aspirate smears, spicule squash/crush preps │
  │ • Molecular testing & FISH analysis                       │
  ├───────────────────────────────────────────────────────────┤
  │ Sodium Heparin (Green Top):                               │
  │ • Cytogenetic analysis (Karyotyping / Chromosome studies) │
  │ • Flow cytometric immunophenotyping                       │
  │ (Heparin preserves viable dividing cells without EDTA     │
  │  induced cytoplasmic or membrane alterations)             │
  └───────────────────────────────────────────────────────────┘

Diagnostic Complementarity: Aspirate vs. Core Biopsy

1. Bone Marrow Aspirate: Yields free individual cells and marrow spicules/particles. Air-dried smears stained with Wright-Giemsa provide superior high-resolution cytologic detail for evaluating nuclear-cytoplasmic maturation, dysplastic changes, blast enumeration, and cytochemical staining.
2. Trephine Core Biopsy: Formalin-fixed, decalcified, and paraffin-embedded histological section stained with H&E. Provides definitive assessment of overall cellularity, spatial architectural relationships (erythroblastic islands, paratrabecular vs interstitial localization), granulomas, metastatic carcinoma nests, and bone trabecular remodeling.
3. Touch Imprints (Roll Preparations): Fresh core biopsy is gently rolled or touched along clean glass slides prior to formalin fixation.
   • "Dry Tap" (Punctio Sicca): Inability to aspirate marrow fluid despite correct needle placement. Common etiologies include Primary Myelofibrosis (PMF) (dense collagen/reticulin meshwork), Hairy Cell Leukemia (HCL) (fibronectin synthesis), and packed hypercellular acute leukemias. Touch preparations provide essential high-resolution single-cell cytomorphology when aspirates yield dry taps.

---

2. Bone Marrow Differential Count & Reference Intervals

A bone marrow differential count is performed on particle-rich aspirate smears by systematically classifying at least 300 to 500 consecutive nucleated hematopoietic cells under oil immersion ($100\times$):

---

3. Myeloid-to-Erythroid (M:E) Ratio Calculation & Interpretation

The Myeloid-to-Erythroid (M:E) ratio expresses the quantitative numerical balance between granulocytic precursors and nucleated erythroid precursors in the bone marrow:

$\text{M:E Ratio} = \frac{\sum \text{Granulocytic / Myeloid Series (Myeloblasts through Segmented Neutrophils, Eos, Basos)}}{\sum \text{Nucleated Erythroid Series (Pronormoblasts through Orthochromic Normoblasts)}}$

                      M:E RATIO CALCULATION RULES

  NUMERATOR (MYELOID LINEAGE):                     DENOMINATOR (ERYTHROID LINEAGE):
  [+] Myeloblasts                                  [+] Pronormoblasts (Rubriblasts)
  [+] Promyelocytes                                [+] Basophilic Normoblasts (Prorubricytes)
  [+] Neutrophilic Myelocytes                      [+] Polychromatophilic Normoblasts (Rubricytes)
  [+] Neutrophilic Metamyelocytes                  [+] Orthochromic Normoblasts (Metarubricytes)
  [+] Neutrophilic Bands
  [+] Segmented Neutrophils
  [+] Eosinophils & Precursors
  [+] Basophils & Precursors

  ═════════════════════════════════════════════════════════════════════════════════
  STRICTLY EXCLUDED FROM BOTH NUMERATOR AND DENOMINATOR:
  [X] Lymphocytes     [X] Plasma Cells     [X] Monocytes & Macrophages
  [X] Megakaryocytes  [X] Osteoblasts      [X] Osteoclasts & Stromal Cells

Reference Intervals

• Normal Adult Range: $1.5:1\text{ to }3.0:1$ (Standard accepted range: $1.5:1\text{ to }4.0:1$; mean adult average $\approx 2.5:1$).

Clinical Differential Diagnosis of Altered M:E Ratios

                         M:E RATIO INTERPRETATION
                                    │
         ┌──────────────────────────┴──────────────────────────┐
         ▼                                                     ▼
[ ELEVATED M:E RATIO (>4:1) ]                         [ DECREASED M:E RATIO (<1.5:1) ]
• MYELOID HYPERPLASIA:                                • ERYTHROID HYPERPLASIA:
  - Severe Bacterial Infection / Leukemoid              - Hemolytic Anemias (Compensatory)
  - Chronic Myeloid Leukemia (CML)                      - Megaloblastic Anemia (Ineffective)
  - Myeloproliferative Neoplasms (MPN)                  - Thalassemia Major / Intermedia
  - G-CSF / GM-CSF Therapy                              - Polycythemia Vera / EPO Therapy
• ERYTHROID HYPOPLASIA:                                 - Acute Blood Loss Recovery
  - Pure Red Cell Aplasia (PRCA)                      • MYELOID HYPOPLASIA:
  - Parvovirus B19 Infection                            - Severe Agranulocytosis
  - Renal Failure (EPO Deficiency)                      - Drug-Induced Myelosuppression

---

4. Assessment of Marrow Cellularity and Bone Marrow Iron

Marrow Cellularity Estimation

Marrow cellularity represents the volumetric proportion of hematopoietic tissue relative to adipose tissue (yellow fat) evaluated on trephine core biopsy sections under low power ($10\times$):

$\text{Expected Normal Adult Cellularity (\%)} = (100 - \text{Patient Age}) \pm 10\%$

• Clinical Example: A 70-year-old patient has an expected cellularity of $(100 - 70) \pm 10% = 30% \pm 10%$ (reference range: $20%\text{ to }40%$).
• Hypercellularity: Exceeds upper age-adjusted limit ($>80 - 90%$ in MPNs, leukemias, or severe hemolytic anemias).
• Hypocellularity: Below lower age-adjusted limit ($<20 - 25%$ in aplastic anemia, hypoplastic MDS, post-chemotherapy aplasia).

Prussian Blue (Perls' Reaction) Stain for Bone Marrow Iron

The Prussian blue reaction treats aspirate smears and core biopsy sections with acid ferrocyanide, which reacts with intracellular ferric iron ($Fe^{3+}$) to form insoluble ferric ferrocyanide (Prussian blue precipitate):

                      PRUSSIAN BLUE MARROW EVALUATION
                                     │
         ┌───────────────────────────┴───────────────────────────┐
         ▼                                                       ▼
MACROPHAGE STORAGE IRON (HEMOSIDERIN)              SIDEROBLAST IDENTIFICATION
• Graded 0 to 4+:                                  • Normal Sideroblasts:
  - 0: Absent (Iron Deficiency Anemia)               - 30–50% of developing normoblasts
  - 1+: Trace / Slightly decreased                   - 1 to 4 fine blue granules (Random)
  - 2+: Normal / Adequate                          • Ring Sideroblasts (Pathologic):
  - 3+: Moderately increased (ACD)                   - ≥5 iron granules encircling ≥1/3
  - 4+: Markedly increased / Coarse clumps             of the nuclear circumference
    (Hemosiderosis / Hemochromatosis)                - MDS-RS (SF3B1 mutation) & Plumbism

1. Macrophage Hemosiderin Storage Iron: Evaluates reticuloendothelial storage reserves in marrow spicules on a standardized 0 to 4+ scale:
   • Grade 0 (Absent): Diagnostic of Iron Deficiency Anemia (IDA).
   • Grade 2+ (Adequate / Normal): Normal physiological iron reserve.
   • Grade 3+ to 4+ (Markedly Increased): Characteristic of Anemia of Chronic Disease (ACD / ACI) (trapped storage iron), Sideroblastic Anemia, and systemic hemochromatosis.
2. Sideroblasts: Developing nucleated red blood cells containing Prussian blue-positive non-heme iron granules:
   • Normal Sideroblasts: Comprise $30%\text{ to }50%$ of normal marrow normoblasts, containing 1 to 4 small, fine, randomly scattered iron granules in the cytoplasm.
   • Ring Sideroblasts: Pathologic normoblasts defined by 5 or more siderotic iron granules encircling at least one-third ($\ge 1/3$) of the nuclear circumference. Ultrastructurally, these granules represent iron-overloaded, swollen mitochondria hugging the nuclear membrane. Hallmark of Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) (associated with somatic mutations in SF3B1) and hereditary/toxin-induced sideroblastic anemias ($ALAS2$ mutation, lead poisoning, chronic alcohol abuse).

---

5. Histochemical Stains for Marrow Fibrosis Grading

                      WHO MARROW FIBROSIS GRADING

  ┌─────────────────────────────────────────────────────────────┐
  │ MF-0: Normal: Scattered linear reticulin; no intersections  │
  │ MF-1: Early: Loose network of reticulin with intersections  │
  │ MF-2: Moderate: Diffuse dense reticulin network with focal  │
  │       thick collagen bundles                                │
  │ MF-3: Advanced: Coarse collagen bundles with osteosclerosis │
  │       and new bone formation (Primary Myelofibrosis)        │
  └─────────────────────────────────────────────────────────────┘

1. Reticulin Silver Stain (Gomori / Snook): Silver impregnation technique that stains fine reticulin (Type III collagen) fibers black. Used to grade myelofibrosis across the WHO scale (MF-0 to MF-3).
2. Masson Trichrome Stain: Stains dense collagen (Type I collagen) vivid blue/green. Identifies advanced, irreversible osteosclerotic collagenous fibrosis in end-stage Primary Myelofibrosis (PMF) and metastatic myelophthisic processes.